The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy
Immunotherapy aims to stimulate the immune system to inhibit tumor growth or prevent metastases. Tumor cells primarily employ altered expression of human leukocyte antigen (HLA) as a mechanism to avoid immune recognition and antitumor immune response. The antitumor immune response is primarily media...
Main Authors: | Lidy Vannessa Mejía-Guarnizo, Paula Stefany Monroy-Camacho, Andrés David Turizo-Smith, Josefa Antonia Rodríguez-García |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1298571/full |
Similar Items
-
Inflammation and cancer: friend or foe?
by: Andrés David Turizo-Smith, et al.
Published: (2024-05-01) -
Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy
by: Xiangyu Yin, et al.
Published: (2024-11-01) -
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
by: Luksika Jiramonai, et al.
Published: (2025-02-01) -
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
by: Zhifei Gao, et al.
Published: (2023-02-01) -
Anaplastic lymphoma kinase-special immunity and immunotherapy
by: Ye Guo, et al.
Published: (2022-07-01)